An Artificial In Vitro Metabolism to Angiopterlactone B Inspired by Traditional Retrosynthesis
Alexander F Kiefer1, Yu-Chang Liu2,1, Rebecca Gummerer1
1Aalto University, Department of Chemistry, Kemistintie 1, 02150, Espoo, Finland.
Angewandte Chemie (International Ed. in English)
|March 20, 2023
Summary
This study introduces artificial metabolism by integrating non-natural biocatalytic modules. This novel approach enables efficient, two-step synthesis of complex molecules like angiopterlactone B in water using enzymes.
Area of Science:
- Biocatalysis and Synthetic Chemistry
- Metabolic Engineering
- Organic Synthesis
Background:
- Biosynthesis offers unparalleled complexity but limited scope.
- Chemical synthesis provides broad scope but lacks biosynthetic elegance.
- Integrating enzymatic and synthetic strategies is a key challenge.
Purpose of the Study:
- To develop an artificial metabolism combining biocatalysis and chemical synthesis.
- To incorporate non-natural enzymatic modules into a synthetic pathway.
- To achieve efficient synthesis of complex natural products.
Main Methods:
- Incorporation of a peroxidase-mediated Achmatowicz rearrangement.
- Integration of a dehydrogenase-catalyzed borrowing-hydrogen-type isomerization.
- Development of a two-step aqueous synthesis pathway.
Main Results:
- Successful integration of non-natural biocatalytic modules into an artificial metabolism.
- Streamlined, two-step total synthesis of tricyclic angiopterlactone B.
- Synthesis achieved entirely in an aqueous environment using enzymes.
Conclusions:
- Artificial metabolism can bridge the gap between biosynthesis and chemical synthesis.
- Enzyme-mediated reactions offer an efficient and environmentally friendly synthetic approach.
- This strategy enables the streamlined synthesis of complex molecular structures.
More Related Videos
Related Concept Videos
Drug Biotransformation: Overview
2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
269
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
269
Drug Metabolism: Phase I Reactions
3.4K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.4K
Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K
Phase I Reactions: Reductive Reactions
238
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
238
Alkylation of β-Ketoester Enolates: Acetoacetic Ester Synthesis
3.5K
Acetoacetic ester synthesis is a method to obtain ketones from alkyl halides and β-keto esters. The reaction occurs in the presence of an alkoxide base that abstracts the acidic proton of the β-keto esters. The step results in an enolate ion which is doubly stabilized. The enolate then reacts with an alkyl halide via the SN2 process to produce an alkylated ester intermediate with a new C–C bond. The hydrolysis of the intermediate, followed by acidification, results in an...
3.5K


